High Tower Advisors, LLC Shockwave Medical, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$191.17 - $325.63 $1.69 Million - $2.88 Million	8,834 Added 440.6%	10,839 $3.53 Million
Q4 2023 Feb 12, 2024	SELL	$160.99 - $215.69 $79,690 - $106,766	-495 Reduced 19.8%	2,005 $382,000
Q3 2023 Nov 08, 2023	BUY	$194.33 - $283.97 $96,776 - $141,417	498 Added 24.88%	2,500 $497,000
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $227,734 - $309,036	1,021 Added 104.08%	2,002 $571,000
Q1 2023 May 11, 2023	SELL	$175.41 - $217.92 $2,806 - $3,486	-16 Reduced 1.6%	981 $212,000
Q4 2022 Feb 08, 2023	SELL	$204.38 - $296.82 $10,014 - $14,544	-49 Reduced 4.68%	997 $204,000
Q3 2022 Nov 09, 2022	BUY	$195.21 - $310.53 $204,189 - $324,814	1,046 New	1,046 $294,000
Q1 2022 May 12, 2022	SELL	$127.96 - $207.36 $153,679 - $249,039	-1,201 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$165.13 - $241.83 $198,321 - $290,437	1,201 New	1,201 $214,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.